Literature DB >> 10803736

The role of intrarenal nitric oxide in the natriuretic response to dopamine-receptor activation.

U Venkatakrishnan1, C Chen, M F Lokhandwala.   

Abstract

Dopamine and dopamine-1 receptor agonists produce diuresis and natriuresis by causing changes in renal hemodynamics and by the activation of dopamine-1 receptors located within the various regions of the nephron. Nitric oxide plays an important role in the maintenance of systemic and regional hemodynamics. The present study was undertaken to investigate the effect of locally generated nitric oxide on renal function and its potential influence on the renal responses to dopamine-1 receptor agonists. The intrarenal infusion of a nitric oxide synthase inhibitor, L-NAME, (50 microg/kg min for 90 min) in anesthetized rats produced significant decreases in urine volume, urinary sodium excretion, glomerular filtration rate and fractional sodium excretion. These changes in renal function were associated with a concomitant decrease in urinary nitrate excretion, an indicator of nitric oxide release. However, L-NAME at this dose did not produce any significant changes in mean arterial pressure or heart rate. Intravenous infusion of fenoldopam (1 microg/kg min for 30 min), a selective dopamine-1 receptor agonist, produced diuresis and natriuresis without causing any changes in mean arterial pressure and heart rate. These renal effects of fenoldopam were significantly attenuated in animals that received the simultaneous infusion of L-NAME (intrarenal). Similar results were obtained with dopamine in that the natriuretic and diuretic response to dopamine was also attenuated during simultaneous infusion of dopamine with L-NAME. In addition, the diuresis and natriuresis produced by fenoldopam and dopamine was associated with increases in urinary nitrate excretion. Interestingly, these increases in the nitrate levels seen with fenoldopam and dopamine were also significantly reduced in the presence of L-NAME. These results indicate that intrarenal nitric oxide plays an important role in regulating renal sodium excretion and that an intact renal nitric oxide system is required for the full expression of diuretic and natriuretic response seen during dopamine-1 receptor activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10803736     DOI: 10.1081/ceh-100100080

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  9 in total

Review 1.  Potential dopamine-1 receptor stimulation in hypertension management.

Authors:  Mohammad Asghar; Seyed K Tayebati; Mustafa F Lokhandwala; Tahir Hussain
Journal:  Curr Hypertens Rep       Date:  2011-08       Impact factor: 5.369

Review 2.  Dopamine receptors: important antihypertensive counterbalance against hypertensive factors.

Authors:  Chunyu Zeng; Pedro A Jose
Journal:  Hypertension       Date:  2010-11-22       Impact factor: 10.190

3.  High doses of simvastatin upregulate dopamine D1 and D2 receptor expression in the rat prefrontal cortex: possible involvement of endothelial nitric oxide synthase.

Authors:  Qing Wang; Wee Lee Ting; Hongyuan Yang; Peter T-H Wong
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

Review 4.  Genetics of salt-sensitive hypertension.

Authors:  Hironobu Sanada; John E Jones; Pedro A Jose
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

Review 5.  Dopamine receptor-coupling defect in hypertension.

Authors:  Pedro A Jose; Gilbert M Eisner; Robin A Felder
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

Review 6.  Diagnostic tools for hypertension and salt sensitivity testing.

Authors:  Robin A Felder; Marquitta J White; Scott M Williams; Pedro A Jose
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-01       Impact factor: 2.894

7.  Regulation of Dopamine Uptake by Vasoactive Peptides in the Kidney.

Authors:  N L Rukavina Mikusic; N M Kouyoumdzian; E Rouvier; M M Gironacci; J E Toblli; B E Fernández; M R Choi
Journal:  Scientifica (Cairo)       Date:  2016-08-22

Review 8.  Dopamine Receptors and the Kidney: An Overview of Health- and Pharmacological-Targeted Implications.

Authors:  Alejandro Olivares-Hernández; Luis Figuero-Pérez; Juan Jesus Cruz-Hernandez; Rogelio González Sarmiento; Ricardo Usategui-Martin; José Pablo Miramontes-González
Journal:  Biomolecules       Date:  2021-02-10

Review 9.  Access to the CNS: Biomarker Strategies for Dopaminergic Treatments.

Authors:  Willem Johan van den Brink; Semra Palic; Isabelle Köhler; Elizabeth Cunera Maria de Lange
Journal:  Pharm Res       Date:  2018-02-15       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.